Waqas Azeem, Ph.D., is currently a Senior Engineer at the Prostate Cancer Therapy Research Group, Department of Clinical Science, University of Bergen, where he also completed his Ph.D. and postdoctoral fellowship. His early academic credentials include Doctor of Veterinary Medicine and M.S. in Molecular Biology. In his Ph.D. under the supervision of Professor Karl-Henning Kalland, he examined regulatory patterns in prostate cell differentiation by investigating the roles of different transcription factors. Thereafter, he was awarded a Helse Vest postdoctoral fellowship where he pursued development program for the robust production of more potent therapeutic dendritic cells in next-generation immunotherapy against cancer.
Waqas Azeem, Ph.D., is currently a Senior Engineer at the Prostate Cancer Therapy Research Group, Department of Clinical Science, University of Bergen, where he also completed his Ph.D. and postdoctoral fellowship. His early academic credentials include Doctor of Veterinary Medicine and M.S. in Molecular Biology. In his Ph.D. under the supervision of Professor Karl-Henning Kalland, he examined regulatory patterns in prostate cell differentiation by investigating the roles of different transcription factors. Thereafter, he was awarded a Helse Vest postdoctoral fellowship where he pursued development program for the robust production of more potent therapeutic dendritic cells in next-generation immunotherapy against cancer.